Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 30;26(19):5949.
doi: 10.3390/molecules26195949.

Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component

Affiliations
Review

Mechanisms and Advances in Anti-Ovarian Cancer with Natural Plants Component

Jingyuan Wu et al. Molecules. .

Abstract

Ovarian cancer ranks seventh in the most common malignant tumors among female disease, which seriously threatens female reproductive health. It is characterized by hidden pathogenesis, missed diagnosis, high reoccurrence rate, and poor prognosis. In clinic, the first-line treatment prioritized debulking surgery with paclitaxel-based chemotherapy. The harsh truth is that female patients are prone to relapse due to the dissemination of tumor cells and drug resistance. In these circumstances, the development of new therapy strategies combined with traditional approaches is conductive to improving the quality of treatment. Among numerous drug resources, botanical compounds have unique advantages due to their potentials in multitarget functions, long application history, and wide availability. Previous studies have revealed the therapeutic effects of bioactive plant components in ovarian cancer. These natural ingredients act as part of the initial treatment or an auxiliary option for maintenance therapy, further reducing the tumor and metastatic burden. In this review, we summarized the functions and mechanisms of natural botanical components applied in human ovarian cancer. We focused on the molecular mechanisms of cell apoptosis, autophagy, RNA and DNA lesion, ROS damage, and the multiple-drug resistance. We aim to provide a theoretical reference for in-depth drug research so as to manage ovarian cancer better in clinic.

Keywords: bioactive compounds; molecular mechanisms; natural plant products; ovarian cancer; traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The various cellular signaling pathways of natural plants components in ovarian cancer.
Figure 2
Figure 2
The role of molecular mechanisms in ovarian cancer.

References

    1. Webb P.M., Jordan S.J. Epidemiology of epithelial ovarian cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 2017;41:3–14. doi: 10.1016/j.bpobgyn.2016.08.006. - DOI - PubMed
    1. Weidle U.H., Birzele F., Kollmorgen G., Rueger R. Mechanisms and Targets Involved in Dissemination of Ovarian Cancer. Cancer Genom. Proteom. 2016;13:407–423. doi: 10.21873/cgp.20004. - DOI - PMC - PubMed
    1. Katabuchi H., Okamura H. Cell biology of human ovarian surface epithelial cells and ovarian carcinogenesis. Med. Electron Microsc. 2003;36:74–86. doi: 10.1007/s00795-002-0196-6. - DOI - PubMed
    1. Duska L.R., Kohn E.C. The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications. Ann. Oncol. 2017;28 doi: 10.1093/annonc/mdx445. - DOI - PMC - PubMed
    1. Grunewald T., Ledermann J.A. Targeted Therapies for Ovarian Cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 2017;41:139–152. doi: 10.1016/j.bpobgyn.2016.12.001. - DOI - PubMed

Substances